VF
XENE icon

Virtu Financial’s Xenon Pharmaceuticals XENE Stock Holding History

Virtu Financial’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,661
Closed -$287K – 1955
2024
Q1 		$287K Buy
+6,661
New +$306K 0.02% 630
2023
Q3 		– Sell
-6,682
Closed -$257K – 1983
2023
Q2 		$257K Buy
+6,682
New +$266K 0.02% 683
2023
Q1 		– Sell
-5,604
Closed -$221K – 2169
2022
Q4 		$221K Buy
+5,604
New +$204K 0.03% 653
2019
Q1 		– Sell
-12,696
Closed -$80K – 1908
2018
Q4 		$80K Buy
+12,696
New +$113K ﹤0.01% 1190

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu Financial's XENE Position: Q2 2024 in Review

Virtu Financial sold out of Xenon Pharmaceuticals (XENE) in Q2 2024, closing a stake of 6,661 shares — an estimated $287K sold.

Virtu Financial first reported a position in XENE in Q4 2018 and held it in 4 quarters. The position peaked at $287K in Q1 2024. 213 funds tracked by Wall St. Rank hold XENE as of Q2 2024.

  • Virtu Financial reported no remaining Xenon Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Virtu Financial sold 6,661 Xenon Pharmaceuticals shares in Q2 2024, an estimated $287K.
  • Virtu Financial first reported a position in Xenon Pharmaceuticals in Q4 2018 and held it in 4 quarters.
  • Virtu Financial's Xenon Pharmaceuticals position peaked at $287K in Q1 2024.
  • 213 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.